Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Do GLP-1s make you sad? Novo Nordisk’s chief scientist is sceptical

Summary by Australian Financial Review
Lotte Bjerre Knudsen played a pivotal role in developing Ozempic and Wegovy. Now she wants to develop a once-a-year injection to make them even more attractive.

1 Articles

Australian Financial ReviewAustralian Financial Review
Lean Right

Do GLP-1s make you sad? Novo Nordisk’s chief scientist is sceptical

Lotte Bjerre Knudsen played a pivotal role in developing Ozempic and Wegovy. Now she wants to develop a once-a-year injection to make them even more attractive.

·Sydney, Australia
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Australian Financial Review broke the news in Sydney, Australia on Monday, March 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Wegovy icon

Wegovy

Ozempic icon

Ozempic

Denmark icon

Denmark

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal